StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$272.70−6.00 (-2.15%)

Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%

Johnson & Johnson pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Johnson & Johnson's pe ratio was 42.6× on Nov 11, 2026, against 20.0× a year earlier. Over the last 5 years it ranged from 9.6× to 42.6×, with a median of 23.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202642.6×+22.6
2025Dec 31, 202520.0×−3.9
2024Dec 31, 202423.9×+12.3
2023Dec 29, 202311.6×−13.0
2022Dec 30, 202224.6×−1.0
2021Dec 31, 202125.6×+0.8
2020Dec 31, 202024.7×−3.0
2019Dec 31, 201927.8×−230.3
2018Dec 31, 2018258.1×+233.8
2017Dec 29, 201724.3×+4.0
2016Dec 30, 201620.2×+0.6
2015Dec 31, 201519.6×+2.3
2014Dec 31, 201417.3×−3.0
2013Dec 31, 201320.4×−2.7
2012Dec 31, 201223.1×+9.3
2011Dec 30, 201113.7×+0.9
2010Dec 31, 201012.8×−3.1
2009Jan 30, 200915.9×–

More Johnson & Johnson figures

See a number that looks wrong?